
Regenerative Medicine
Friday, May 15, 2009 - Saturday, May 16, 2009
Presented By
Presented by the New York Academy of Sciences, the Chinese Academy of Medical Sciences, the Chinese Academy of Sciences, and the Chinese Ministry of Health
This May, experts from academia and the pharmaceutical industry will convene in Beijing, China for an exciting 2-day event on Regenerative Medicine. Regenerative medicine represents a frontier field in medical treatments and China, with a host of new national initiatives aimed at advancing regenerative medicine research, is an ideal location to host this international, interdisciplinary meeting.
Silver Sponsors
Agenda
Day 1: Friday, May 15, 2009 | |
8:00 am – 9:00 am: | Registration |
9:00 am – 10:00 am: | Welcome and Opening Remarks |
Chen Zhu, PhD, Minister, Ministry of Health of the People's Republic of China Ellis Rubinstein, President, The New York Academy of Sciences Depei Liu, President, Chinese Academy of Medical Sciences Cecilia Chan, Managing Director, Octonovem Torsten Wiesel, MD, Nobel Laureate, Chairman-Emeritus, The New York Academy of Sciences and President-Emeritus, The Rockefeller University Gerald Chan, Co-Founder, Morningside Group | |
10:00 am – 10:30 am: | Coffee Break |
Session I: PhysiologyModerator: Tao Cheng, Deputy Director and Professor, Institute of Hematology, Chinese Academy of Medical Sciences | |
10:30 am – 12:00 noon: | Tao Cheng, Deputy Director and Professor, Institute of Hematology, Chinese Academy of Medical Sciences Assembly of Mature Ventricular Muscle from ESC-derived Progenitors Yong Zhao, PhD, The Institute of Zoology (IOZ), within The Chinese Academy of Sciences (CAS) |
12:00 noon – 1:30 pm: | Lunch and Poster Session |
Session II: Stem CellsModerator: Stacie Bloom, PhD, The New York Academy of Sciences | |
1:30 pm – 3:30 pm: | Chunhua Zhao, MD, PhD, The Chinese Academy of Medical Sciences, Center of Tissue Engineering Differentiation of Induced Pluripotent Stem (iPS) Cells into Functional Cardiomyocytes Hongkui Deng, PhD, School of Life Sciences, Peking University Improvement of Chemotherapy Specificity towards Cancer Cells hile Sparing Normal Hematopoietic Stem and Progenitor Cells by Interleukin 1 Receptor Antagonist |
3:30 pm – 4:00 pm: | Coffee Break |
Session III: OrganogenesisModerator: Yilin Cao, MD, PhD, Director and Professor, Plastic Surgery Hospital, Chinese Academy of Medical Sciences | |
4:00 pm – 6:00 pm: | Regenerative Medicine: Cell-based Technologies for Clinical Translation Yilin Cao, MD, PhD, Director and Professor, Plastic Surgery Hospital, Chinese Academy of Medical Sciences Cell Therapy for Cardiovascular Diseases: Mechanisms and Clinical Application Pei Xue Tao, Institute of Blood Transfusion, Academy of Military Medical Sciences, Beijing |
Day 2: Saturday, May 16, 2009 | |
8:30 am – 9:00 am: | Registration |
Keynote Address | |
9:00 am – 9:40 am: | Normal and Neoplastic Stem Cell |
9:40 am – 10:00 am: | Coffee Break |
Session IV: Transplantation and ToleranceModerator: Douglas Braaten, PhD, The New York Academy of Sciences | |
10:00 am – 12:00 pm: | Barriers to Transplantation Tolerance Wei Wang, Director, Center of Cell Transplantation and Gene Therapy, Zhongnan University Youping Li, Director, Chinese Cochrane Center, Sichuan University Wei Liu, Shanghai Jiatong University |
12:00 pm – 2:00 pm: | Lunch |
Breakout Session - Panel: Careers in SciencesCo-Moderators: Kathy Granger, PhD, The New York Academy of Sciences and Qimin Zhan, Vice President, Chinese Academy of Medical Sciences | 12:45 pm – 1:45 pm: | ACADEMIC CORPORATE FINANCE NON-PROFIT PUBLISHING |
Session V: Nanomaterials and NantechnologyModerator: Ning Gu, President, Dongnan University School of Life Sciences and Medical Engineering | |
2:00 pm – 4:30 pm: | Nanotechnology for Regenerating Tissues: Hype or Reality? Haiyan Xu, Director, Center of Nanomaterials, Chinese Academy of Medical Sciences Cell Microenvironment at the Nanometer Level and the Control of Regeneration Ning Gu, President, Dongnan University School of Life Sciences and Medical Engineering |
4:30 pm – 5:00 pm: | Coffee Break |
Session VI: Finance PanelModerator: Gerald Chan | |
5:00 pm – 6:30pm: | Panelists: Leon Chen, PhD, Partner, Fidelity Asia Ventures Brock Reeve, Executive Director, Harvard Stem Cell Institute Leonide Saad, PhD, Vice President, Proteus Venture Partners Richard L. Sprott, PhD, Executive Director, The Ellison Medical Foundation Adam Zhu, Chief Representative of Beijing Office, Merrill Lynch International Incorporated Alex Fowkes, Executive Director, Pfizer (China) Research & Development Co. Ltd |
6:30 pm – 7:00 pm: | Closing Statements |
Evening | Banquet Reception |
Speakers
Honorary Committee
Depei Liu
President, Chinese Academy of Medical Sciences
Ellis Rubinstein
President, New York Academy of Sciences
Chen Zhu, PhD
Chinese Minister of HealthGerald Chan, Morningside Group Co-Founder
Torsten Wiesel, MD
Nobel Laureate, Chairman-emeritus of the New York Academy of Sciences and President-emeritus at Rockefeller University
Cecilia Chan
Octonovem Managing Director
John Niblack
Former Pfizer President for Global R&D
Scientific Organizing Committee
Anthony Atala, MD
Wake Forest University
Stacie Bloom, PhD
The New York Academy of Sciences
Yilin Cao, MD, PhD
Shanghai Jiao Tong University School of Medicine
Anita Chong, PhD
University of Chicago
Stephanie Dimmeler, PhD
University of Frankfurt
Michael P. Sheetz, PhD
Columbia University
Thomas Webster, PhD
Brown University
Zhan Qi Ming
Chinese Academy of Medical Sciences
Alex Zhang
Sanofi-Aventis
Chun Hua Zhao
China National Stem Cell Research Center
Keynote Speaker
Irving L. Weisman, MD
Stanford University School of Medicine
Speakers
Yilin Cao, MD, PhD
Chinese Academy of Medical Sciences
Douglas Braaten, PhD
The New York Academy of Sciences
Gerald Chan
Morningside Group
Leon Chen, PhD
Fidelity Asia Ventures
Tao Cheng
The Chinese Academy of Medical Sciences
Anita S. Chong, PhD
The University of Chicago
Hongkui Deng, PhD
Peking University
Stefanie Dimmeler, PhD
University of Frankfurt
Ibrahim J. Domian MD, PhD
Richard B. Simches Research Center
Alex Fowkes
Pfizer (China) Research & Development Co. Ltd
Kathy Granger, PhD
The New York Academy of Sciences
Ning Gu
Dongnan University
Wei Han, PhD
Shanghai Jiatong University
Youping Li
Sichuan University
Wei Liu
Shanghai Jiatong University
Ulrich Martin, PhD
Hannover Medical School
Brock Reeve
Harvard Stem Cell Institute
Leonide Saad, PhD
Proteus Venture Partners
Michael P. Sheetz, PhD
Columbia University
Richard L. Sprott, PhD
The Ellison Medical Foundation
Alison Tan-Mulligan, MD
WorldLink Medical Group in Shanghai
Pei Xue Tao
Academy of Military Medical Sciences, Beijing
Wei Wang
Zhongnan University
Thomas J. Webster, PhD
Brown University
Haiyan Xu
The Chinese Academy of Medical Sciences
James Yoo, MD, PhD
Wake Forest Institute for Regenerative Medicine
Qimin Zhan
The Chinese Academy of Medical Sciences
Chunhua Zhao, MD, PhD
The Chinese Academy of Medical Sciences
Yong Zhao, PhD
The Chinese Academy of Sciences
Adam Zhu
Merrill Lynch International Incorporated